MedTrace Logo

Primary PCI in Patients With ST-elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization

NCT01960933 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 650

Last updated 2023-11-28

No results posted yet for this study

Summary

In patients with ST-elevation myocardial infarction (STEMI) the primary treatment is acute angioplasty of the acute occlusion (culprit lesion). In STEMI patients with multi vessel disease (MVD) no evidence based treatment of the non-culprit lesions exists. We aim to provide evidence as to whether full revascularization or revascularization of the culprit lesion only provides the best prognosis for the patient.

Conditions

  • ST-elevation Myocardial Infarction
  • Multi Vessel Disease

Interventions

PROCEDURE

Percutaneous coronary intervention

PROCEDURE

FFR

Sponsors & Collaborators

  • Aalborg University Hospital

    collaborator OTHER

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Steffen Helqvist, MD, DMSci · Rigshospitalet, University of Copenhagen, Denmark

  • Thomas Engstrøm, MD, DMSci · Rigshospitalet, University of Copenhagen, Denmark

  • Henning Kelbæk, MD. DMSci · Rigshospitalet, University of Copenhagen, Denmark

  • Lars Køber, MD, Prof., DMSci · Rigshospitalet, University of Copenhagen, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2015-02-28
Completion
2024-02-29

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01960933 on ClinicalTrials.gov